Company:  ADAMIS PHARMACEUTICALS CO ... (ADMP)
Form Type:  10-K
Filing Date:  3/30/2020 
CIK:  0000887247 
Address:  11682 EL CAMINO REAL
SUITE 300
 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 997-2400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.54  
Change: 
0.0267 (5.19%)  
Trade Time: 
01:28 PM EST  
Market Cap: 
$39.89M
Trade ADMP now with 

© 2020  
Description of Business
Adamis Pharmaceuticals Corporation ("we," "us," "our," "Adamis" or the "company") is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy and opioid overdose. Our products and product candidates in the allergy, respiratory, and opioid overdose markets include: SYMJEPI(TM) (epinephrine) Injection 0.3mg, which was approved by the U.S.
Register and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. BUSINESS
      ITEM 1A. RISK FACTORS
      ITEM 1B. UNRESOLVED STAFF COMMENTS
      ITEM 2. PROPERTIES
      ITEM 3. LEGAL PROCEEDINGS
      ITEM 4. MINE SAFETY DISCLOSURES
    PART II
      ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        Results of Operations
        Liquidity and Capital Resources
      ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
      ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      ITEM 9A. CONTROLS AND PROCEDURES
      Report of Independent Registered Public Accounting Firm on ...
      Report of Independent Registered Public Accounting Firm
      ITEM 9B. OTHER INFORMATION
    PART III
      ITEM 10: DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
      ITEM 11: EXECUTIVE COMPENSATION
      ITEM 12: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND ...
      ITEM 13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND ...
      ITEM 14: PRINCIPAL ACCOUNTING FEES AND SERVICES
    PART IV
      ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
    SIGNATURES
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    CASH FLOW
    Notes to the Consolidated Financial Statements
      NOTE 21: SUBSEQUENT EVENTS
  EXHIBIT 4.6
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO SECTION 302 OF THE
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO SECTION 302 OF THE
  EXHIBIT 32.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 32.2
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER